APA
25
5
IR
68
-3
CTSH
63
-2
PBI
59
-6
KSS
46
4
EXC
53
12
SYK
71
-2
DFS
64
-3
DNB
82
-4
ECL
59
-3
CSCO
61
-6
NRG
47
-3
NDAQ
59
-4
WDC
41
3
GS
69
-6
SWKS
36
3
MSI
76
-3
ZION
67
-4
CMCSA
53
-2
HCA
51
-2
APA
25
5
IR
68
-3
CTSH
63
-2
PBI
59
-6
KSS
46
4
EXC
53
12
SYK
71
-2
DFS
64
-3
DNB
82
-4
ECL
59
-3
CSCO
61
-6
NRG
47
-3
NDAQ
59
-4
WDC
41
3
GS
69
-6
SWKS
36
3
MSI
76
-3
ZION
67
-4
CMCSA
53
-2
HCA
51
-2
Financhill
Back

ProPhase Labs Quote, Financials, Valuation and Earnings

Trump's "Document 20" Revealed: Smart Americans Could Get Rich During His 2nd Term

See if stocks could soar as much as 1,000% if history repeats itself.
Sell
22

PRPH
ProPhase Labs

Last Price:
0.74
Seasonality Move:
18.16%

7 Day Trial

ALL ACCESS PASS

$ 7

America's enemies are regrouping & it may sucker punch your savings

Click here to learn more.

ProPhase Labs Price Quote

$0.74
-0.01 (-1.52%)
(Updated: November 15, 2024 at 5:55 PM ET)

ProPhase Labs Key Stats

Sell
22
ProPhase Labs (PRPH) is a Sell
Day range:
$0.75 - $0.79
52-week range:
$0.66 - $7.48
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.75
P/B ratio:
0.33%
Volume:
339.6K
Avg. volume:
174.1K
1-year change:
-82.73%
Market cap:
$14.3M
Revenue:
$44.4M
EPS:
$-1.49

How Much Does ProPhase Labs Make?

Is ProPhase Labs Growing As A Company?

  • What Is ProPhase Labs's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.81%
  • What Is ProPhase Labs's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

ProPhase Labs Stock Price Performance

  • Did ProPhase Labs Stock Go Up Last Month?
    ProPhase Labs share price went down by -68.69% last month
  • Did PRPH's Share Price Rise Over The Last Year?
    PRPH share price fell by -82.73% over the past 1 year

What Is ProPhase Labs 52-Week High & Low?

ProPhase Labs Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy ProPhase Labs?

  • How Much Debt Does ProPhase Labs Have?
    Total long term debt quarterly is $13.6M
  • How Much Cash Does ProPhase Labs Have?
    Cash and short term investments quarterly total is $1.8M
  • What Is ProPhase Labs’s Book Value Per Share?
    Book value per share is 2.31

Is ProPhase Labs Cash Flow Positive?

  • What Is PRPH Cash Flow From Operations?
    Cash flow from operations (TTM) is -$14.8M
  • What Is ProPhase Labs’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $11.7M
  • What Is ProPhase Labs’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $1.6M

ProPhase Labs Return On Invested Capital

  • Is Management Doing A Good Job?
    PRPH return on invested capital is -42.78%
  • What Is ProPhase Labs Return On Assets?
    ROA measures how assets are converting to revenues and is -28.7%
  • What Is PRPH Return On Equity?
    ROE is a measure of profitability and is -51.79%

ProPhase Labs Earnings Date & Stock Price

ProPhase Labs Competitors

  • Who Are ProPhase Labs's Competitors?
    Below is a list of companies who compete with ProPhase Labs or are related in some way:
    • Applied DNA Sciences Inc (APDN)
    • Fonar Corp (FONR)
    • OncoCyte Corp (OCX)
    • Veracyte Inc (VCYT)
    • XWELL Inc (XWEL)

ProPhase Labs Dividend Yield

ProPhase Labs Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -12.9%
Revenue: -81.28% 11.56%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 18.50
Upside from Last Price: 2362.07%

Major Shareholders

  • How many PRPH shares are owned by institutional investors?
    2.5M PRPH shares are owned by institutional investors
  • How many PRPH shares are owned by insiders?
    9.1M PRPH shares are owned by insiders